Skin Booster Ingredients & Lump Risk: HA vs Stimulators

Under the same name "skin booster," why does one person just get hydration and glow, while another ends up with a repeatedly swelling lump?

The key is this — "skin booster" isn't a single product at all; it's an umbrella term for a whole category of treatments. It's all delivered into the superficial dermis via multi-needle or negative-pressure systems, but "what's delivered" varies enormously between clinics — and that ingredient is the single biggest variable determining the risk of lumps and nodules.

This article sorts common booster formulas into risk tiers by ingredient, in a clear table, so you can see where the risk sits before deciding which one to get.

First principle: skin booster risk follows the ingredient

Booster contents broadly fall into a few groups, commonly:

• Plain hyaluronic acid (HA): non-cross-linked or lightly cross-linked small-molecule HA, mainly for hydration, brightening, and fine lines.
• HA + nutrient blends: HA base plus vitamin C, tranexamic acid, amino acids, micro-dose botulinum, etc., targeting tone, oiliness, pores.
• With autologous components (PRP, etc.): mixing your own platelet-rich plasma into the injection, marketed for regeneration.
• With a collagen stimulator: adding diluted microdroplets of a collagen stimulator — commonly PLLA (poly-L-lactic acid, the active ingredient in Sculptra), PDLLA (poly-D,L-lactic acid, the active ingredient in AestheFill), PCL (polycaprolactone, the active ingredient in Ellansé), or CaHA (calcium hydroxylapatite, the active ingredient in Radiesse) — marketed to stimulate your own collagen.

These may look similar in their hydrating effect, but for "lump risk" they are not in the same league. The next section lays out the gap directly in a tier table.

Skin booster ingredient risk-tier table

The tiers below address the risk of forming lumps, nodules, and granulomas — not short-term reactions like redness or bruising. Risk levels are relative comparisons; individual constitution and injection technique still affect actual outcomes.

As you can see, what really makes risk "jump a tier" is the collagen stimulator row. The other tiers are gradual; only adding a collagen stimulator pushes the risk up a clear notch.

Key point: Spending the same money on a booster, the difference isn't just in effect — it's in risk. Before you compare "which is cheaper, which works better," first figure out "which tier of booster is this." That's the real first step in protecting yourself.

Why the "collagen stimulator" tier carries the highest risk

The way a collagen stimulator works is, by design, to provoke a controlled mild inflammation that stimulates fibroblasts to grow collagen. The problem: in certain constitutions and areas this inflammation overshoots, and what grows isn't collagen but a granuloma (a firm nodule formed when immune cells wall off a foreign material).

Nodules feature in published cases of foreign-body granulomas after collagen-stimulating fillers. Those reports start with people who already had a complication; they cannot tell us the rate among everyone injected (Wang et al., Journal of Cosmetic Dermatology, 2025, PMID 41132036). A papule, a palpable PLLA nodule, and a granuloma are different outcomes. A selected ten-person delayed-symptom series recorded onset at 6–60 months, and one separate case appeared about nine years later; neither gives a usual latency for everyone treated (Alijotas-Reig et al., Dermatology, 2009, PMID 19797889; Seo et al., Skin Research and Technology, 2024, PMID 38563152). Both stimulation and a later lump call for attention to how tissue responds to the material. A smooth early course does not guarantee the same later.

If you already have filler or a lump, I check the material and the lesion before discussing whether another injection suits you. Whether a collagen stimulator wakes up old filler is not something its mechanism alone can tell you. See the mechanism and risks of collagen stimulators, the immune mechanism of granuloma formation, and skin boosters with existing filler lumps.

This is why, for anyone with existing filler lumps or pillow face, our booster formula never contains a collagen stimulator.

Before treatment, how to ask "what's in this booster"

Since skin booster risk is tied to the ingredient, the most practical self-protection is to ask about the ingredient before getting it. You can ask:

• "What's the main ingredient of this booster? Is it plain HA, or does it contain a collagen stimulator (PLLA / CaHA)?"
• "If I've had filler before, will this ingredient interact with it?"
• "Will you look at the current state of my face first (e.g. with ultrasound) before injecting?"
• "If a persistent lump appears afterward, how is it handled?"

A booster treatment willing to explain its ingredients clearly and to understand your face's current state first is far safer than one that "can't name its ingredients and only emphasizes the effect." If you're not yet clear on how boosters themselves are delivered, see the difference between skin booster needles and guns.

Key point: "Can't explain the ingredients clearly" is itself a warning sign. You have the right to know what's being injected into your face — that's not being difficult, it's basic informed consent.

Closing: understand the ingredient first, then decide which to get

Back to the opening question: why does the same "skin booster" carry such different risk? Because a booster was never one thing — it's a whole category. What truly determines lump risk is the ingredient inside, not the words "skin booster."

Understand the tiers, ask about the ingredient, and when needed confirm first whether you have old filler in your face — and you can make the safest choice for yourself between "hydration and glow" and "avoiding lumps." If you've had filler before and want a booster but aren't sure which one suits you, you're welcome to have Dr. Ta-Ju Liu assess you personally with ultrasound: see the current state clearly, then decide. For more on managing filler-related issues, see our filler revision specialty.

Frequently Asked Questions

Does plain HA never cause lumps?

The risk is relatively low, but it isn't zero. Plain HA (non-cross-linked or lightly cross-linked small-molecule) isn't designed to stimulate collagen; it mainly does hydration, brightening, and fine lines, which is why it sits in the lower tier for lumps and nodules. Rare delayed-onset nodules (DON) are still possible, just at low probability. The word I want to stress is "relative": the tier table compares relative risk, and your individual constitution and the injection technique still affect the actual outcome.

Why does adding a collagen stimulator push the risk up a tier?

Because collagen stimulators prompt fibroblasts and nearby tissue to respond. If the reaction overshoots, a nodule or granuloma may appear instead of the hoped-for improvement. The case review mentioned above only describes people who already developed granulomas; it cannot estimate risk for everyone treated (Wang et al., Journal of Cosmetic Dermatology, 2025, PMID 41132036). A PLLA lump can also appear much later, so no fixed month range promises safety. Adding a collagen stimulator calls for a more cautious tier of assessment.

PRP is my own blood — doesn't that make it safe?

Autologous components are relatively compatible, that part is true, which is why PRP sits in the moderate row of the table. But one thing to keep in mind: it's still an injection event. For someone who already has filler in their face, any injection can act as a stimulus. So this tier is harder to generalize about — it depends on what's currently in your face, and where the injection goes.

I've had filler before. Can I still get a skin booster?

First check the booster ingredients, and what material is still in your face. If an old filler area swells after a later treatment, timing alone cannot show that a collagen stimulator activated it. Our booster formula contains no collagen stimulator for patients with existing lumps or excess filler. One more thing worth flagging: what you remember having had done, and what is actually still in your face, are often not the same thing. Ultrasound identifies the material, the site, and the lesion before we decide on another injection.

What should I ask the clinic before treatment?

Since booster risk is tied to the ingredient, the most practical self-protection is to ask about the ingredient before you get it. You can ask: what's the main ingredient of this booster — plain HA, or does it contain a collagen stimulator (PLLA / CaHA)? If I've had filler before, will this ingredient interact with it? Will you look at the current state of my face first, for example with ultrasound? If a persistent lump appears afterwards, how is it handled? A booster treatment willing to explain its ingredients clearly and to understand your face's current state first is far safer than one that can't name its ingredients and only emphasizes the effect. "Can't explain the ingredients clearly" is itself a warning sign — you have the right to know what's being injected into your face, and that's not being difficult, it's basic informed consent.

This article is educational information and cannot replace an individual in-person assessment. The ingredient and treatment actually suitable for you must be judged by a physician based on your individual situation.